433 related articles for article (PubMed ID: 25172387)
21. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
Lu N; Sun Y; Zheng X
Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
[TBL] [Abstract][Full Text] [Related]
22. Distinct mPTP activation mechanisms in ischaemia-reperfusion: contributions of Ca2+, ROS, pH, and inorganic polyphosphate.
Seidlmayer LK; Juettner VV; Kettlewell S; Pavlov EV; Blatter LA; Dedkova EN
Cardiovasc Res; 2015 May; 106(2):237-48. PubMed ID: 25742913
[TBL] [Abstract][Full Text] [Related]
23. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG
J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.
Clarke SJ; Khaliulin I; Das M; Parker JE; Heesom KJ; Halestrap AP
Circ Res; 2008 May; 102(9):1082-90. PubMed ID: 18356542
[TBL] [Abstract][Full Text] [Related]
25. The mitochondrial permeability transition pore is a dispensable element for mitochondrial calcium efflux.
De Marchi E; Bonora M; Giorgi C; Pinton P
Cell Calcium; 2014 Jul; 56(1):1-13. PubMed ID: 24755650
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I/R Injury.
Mendoza A; Patel P; Robichaux D; Ramirez D; Karch J
Circ Res; 2024 May; 134(10):1292-1305. PubMed ID: 38618716
[TBL] [Abstract][Full Text] [Related]
27. The role of succinate and ROS in reperfusion injury - A critical appraisal.
Andrienko TN; Pasdois P; Pereira GC; Ovens MJ; Halestrap AP
J Mol Cell Cardiol; 2017 Sep; 110():1-14. PubMed ID: 28689004
[TBL] [Abstract][Full Text] [Related]
28. Targeting cell death.
Hausenloy DJ; Scorrano L
Clin Pharmacol Ther; 2007 Oct; 82(4):370-3. PubMed ID: 17851576
[TBL] [Abstract][Full Text] [Related]
29. Tilianin Post-Conditioning Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondrial Protection and Inhibition of Apoptosis.
Wang Y; Yuan Y; Wang X; Wang Y; Cheng J; Tian L; Guo X; Qin D; Cao W
Med Sci Monit; 2017 Sep; 23():4490-4499. PubMed ID: 28922345
[TBL] [Abstract][Full Text] [Related]
30. The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury.
Bland AR; Payne FM; Ashton JC; Jamialahmadi T; Sahebkar A
Pharmacol Res; 2022 Jan; 175():105986. PubMed ID: 34800627
[TBL] [Abstract][Full Text] [Related]
31. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
Eur J Pharmacol; 2009 Feb; 604(1-3):111-6. PubMed ID: 19135050
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
[TBL] [Abstract][Full Text] [Related]
33. Real-Time Fluorescence Measurements of ROS and [Ca2+] in Ischemic / Reperfused Rat Hearts: Detectable Increases Occur only after Mitochondrial Pore Opening and Are Attenuated by Ischemic Preconditioning.
Andrienko T; Pasdois P; Rossbach A; Halestrap AP
PLoS One; 2016; 11(12):e0167300. PubMed ID: 27907091
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion.
Boengler K; Hilfiker-Kleiner D; Heusch G; Schulz R
Basic Res Cardiol; 2010 Nov; 105(6):771-85. PubMed ID: 20960209
[TBL] [Abstract][Full Text] [Related]
35. B-type natriuretic peptide-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
Sun Y; Zhang Y; Yan M; Wu Y; Zheng X
Biol Pharm Bull; 2009 Sep; 32(9):1545-51. PubMed ID: 19721230
[TBL] [Abstract][Full Text] [Related]
36. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.
Miura T; Tanno M
Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903
[TBL] [Abstract][Full Text] [Related]
37. Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore.
Elrod JW; Molkentin JD
Circ J; 2013; 77(5):1111-22. PubMed ID: 23538482
[TBL] [Abstract][Full Text] [Related]
38. Role of mitochondrial permeability transition pore and mitochondrial ATP-sensitive potassium channels in the protective effects of ischemic preconditioning in isolated hearts from fed and fasted rats.
Prendes MG; Hermann R; Torresin ME; Vélez D; Savino EA; Varela A
J Physiol Biochem; 2014 Sep; 70(3):791-800. PubMed ID: 25034332
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic Role of mPTP in Ischemia-Reperfusion Injury.
Morciano G; Bonora M; Campo G; Aquila G; Rizzo P; Giorgi C; Wieckowski MR; Pinton P
Adv Exp Med Biol; 2017; 982():169-189. PubMed ID: 28551787
[TBL] [Abstract][Full Text] [Related]
40. Abnormal mitochondrial function during ischemia reperfusion provides targets for pharmacological therapy.
García-Rivas GJ; Torre-Amione G
Methodist Debakey Cardiovasc J; 2009; 5(3):2-7. PubMed ID: 20308957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
